Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Targeted Therapy
- Lymphoma
- Endometrial Cancer
- Endoscopy Methods
- Bladder Cancer
- Blood Cancer
- Haemato-Oncology
- Radiation Oncology
Abstract
Citation: Clin Oncol. 2021;6(1):1804.DOI: 10.25107/2474-1663.1804
Prevalence of Obesity in Breast Cancer Patients of Pakistan
Uroos Amir, Yumna Saleem, SundasIshaque and Rufina Soomro
Department of General Surgery, Liaquat National Hospital, Karachi, Pakistan
*Correspondance to: Uroos Amir
PDF Full Text Research Article | Open Access
Abstract:
Objective: To determine the prevalence of obesity in breast cancer patients, in addition to its relation with menopausal status.
Study Design: Cross-sectional Study, Convenience sampling.
Place and Duration: This study was conducted in a tertiary care hospital setting from October 2018 to December 2020 for a period of 2 years.
Materials and Methods: A total of 311 women diagnosed with breast cancer, selected randomly from outpatients were recruited. Based on BMI (Body Mass Index) that was calculated from patients registered height and weight. Prevalence of overweight (BMI ≥ 25 <30), obese (BMI ≥ 30 <40), and severely obese (BMI ≥ 40) breast cancer patients was determined and their association with
menopausal statuses was also analyzed.
Result: Breast Cancer patients in Pakistan had a prevalence of overweight of 34.4%, obesity of 39.2% and severely obese of 7.4%. The mean BMI was above normal for pre-menopause, perimenopause and postmenopausal patients (28.2, 33.4, and 30.7 respectively).
Conclusion: Breast cancer patients in Pakistan show a significant prevalence of overweight and obesity. Obesity is especially predominant in perimenopause and postmenopausal breast cancer patients in our population.
Keywords:
Breast cancer; Overweight; Obesity; Menopausal status
Cite the Article:
Amir U, Saleem Y, SundasIshaque, Soomro R. Prevalence of Obesity in Breast Cancer Patients of Pakistan. Clin Oncol. 2021;6:1804..